Clinical Trials Directory

Trials / Completed

CompletedNCT03782051

Combined Viscocanalostomy, Phacoemulsification, OIogen Implant in Open Angle Glaucoma

Combined Phacoemulsification and Viscocanalostomy With Ologen Implant Versus Combined Phacoemulsification and Viscocanalostomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
81 (actual)
Sponsor
Zagazig University · Other Government
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

This prospective, interventional, randomized clinical study was done at Alpha Vision Center, Zagazig, Egypt. Patients with coexisting cataract and glaucoma were randomized to receive either phaco-viscocanalostomy (Phacovisco group) or phaco-viscocanalostomy with Ologen® implant (OloPhacovisco group) . Follow-up period was 2 years. Nd:YAG laser goniopuncture was done in cases where the intraocular pressure (IOP) was elevated above 21 mmHg after discontinuation of corticosteroid eye drops at any follow-up visit. Our hypothesis is that using Ologen® implant as a spacer in the subscleral reservoir in phaco-viscocanalostomy reduces fibrosis and increase the success rate of this operation

Detailed description

Background: To study the efficacy of the biodegradable collagen implant Ologen® as an adjuvant in phaco-viscocanalostomy in patients with coexisting cataract and primary open angle glaucoma. Methods: This prospective, interventional, randomized clinical study was done at Alpha Vision Center, Zagazig, Egypt. Patients with coexisting cataract and glaucoma were randomized to receive either phaco-viscocanalostomy (Phacovisco group) or phaco-viscocanalostomy with Ologen® implant (OloPhacovisco group). Follow-up period was 2 years. Nd:YAG laser goniopuncture was done in cases where the intraocular pressure (IOP) was elevated above 21 mmHg after discontinuation of corticosteroid eye drops at any follow-up visit.

Conditions

Interventions

TypeNameDescription
PROCEDUREcombined phacoemulsification and viscocanalostomyphacoemulsification with viscocanalostomy
PROCEDUREcombined phacoemulsification and viscocanalostomy and ologenphacoemulsification with viscocanalostomy with ologen

Timeline

Start date
2013-08-01
Primary completion
2018-01-14
Completion
2018-01-14
First posted
2018-12-20
Last updated
2018-12-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03782051. Inclusion in this directory is not an endorsement.